Stephen Rocamboli is Director at TFF Pharmaceuticals, Inc. (TFFP). They have made 7 open-market trades across 3 companies since 2008, most recently 2025-05-29.
CIK 0001221451
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $43K since 2008, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TFFP | BUY | 2023-08-15 | 2023-08-15 | $0.25 | $5K | -1.5% | -2.6% | -43.6% |
| ESPR | BUY | 2023-05-10 | 2023-05-11 | $1.50 | $12K | +7.9% | -18.5% | +5.3% |
| TFFP | BUY | 2023-03-10 | 2023-03-13 | $0.80 | $10K | -9.2% | -19.8% | -43.3% |
| TFFP | BUY | 2022-05-16 | 2022-05-17 | $4.54 | $14K | +20.2% | +5.1% | +15.0% |
| TFFP | SELL | 2021-03-15 | 2021-03-17 | $16.85 | $674K | -19.5% | -26.9% | -32.1% |
| TFFP | SELL | 2020-11-10 | 2020-11-13 | $15.40 | $1.1M | -6.6% | -16.5% | +8.4% |
| VQPH | BUY | 2008-01-14 | 2008-01-14 | $0.11 | $2K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.